Xiaofeng He

Domestic Capital Market, Information Disclosure Compliance, Securities Compliance and Investigation

0755-8958 5892 hexiaofeng@chonglilaw.com

Xiaofeng He specializes in domestic capital markets, information disclosure compliance, and securities compliance and investigations. She has extensive experience advising on IPOs, private placements, mergers and acquisitions, information disclosure, and regulatory compliance. Her practice primarily focuses on providing legal services to listed and pre-IPO companies, with a strong command of capital markets regulations and practices in China.

 

Prior to joining Chong Li Law Firm, Ms. He practiced at Grandway Law Offices (Shenzhen) and a well-known domestic securities compliance consulting firm.


Representative Matters


Domestic Capital Market

 

  • Acted as issuer’s counsel in the IPO and ChiNext listing of Yidong Electronic Technology Co., Ltd. (301123.SZ)

  • Acted as issuer’s counsel in the 2022 non-public A-share offering by Great Wall Securities Co., Ltd. (002939.SZ)

  • Provided legal support for a Main Board-listed company in the proposed spin-off and domestic listing of its subsidiary

  • Represented an issuer in its proposed IPO and ChiNext listing project in Xi’an

  • Represented a securities firm in a proposed STAR Market IPO by a Shenzhen-based company


Information Disclosure Compliance

 

  • Advised A-share listed companies including Runben Biotechnology (603193.SH), Mypin Medical (301033.SZ), KraußMaffei (600579.SH), Huazi Industrial (600191.SH), and Hoppt Battery (001283.SZ) on various information disclosure and compliance matters

  • Assisted clients in interpreting disclosure rules, preparing periodic and ad hoc reports, and enhancing overall disclosure quality


Securities Compliance & Investigation

 

  • Provided governance optimization services to two ChiNext-listed companies in Guangdong

  • Conducted comprehensive reviews and issued improvement recommendations on information disclosure, board and shareholder meeting procedures, internal controls, and investor relations management to mitigate regulatory risks